Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00075 USD | -10.71% |
|
-20.00% | -93.33% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Josef Zelinger
BRD | Director/Board Member | 74 | 20-12-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1 | 0 | 0 | 99.78 % |
Stock B | 1 | 331,935,348 | 331,216,641 ( 99.78 %) | 0 |
Company contact information
Propanc Biopharma, Inc.
6 Butler Street Suite 302
3124, Camberwell
+61 3 9882 0780
http://www.propanc.com![address Propanc Biopharma, Inc.(PPCB)](https://cdn.zonebourse.com/static/address/120794553.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-93.33% | 137K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- PPCB Stock
- Company Propanc Biopharma, Inc.